Drug Shortage Report for POSANOL
| Report ID | 244160 |
| Drug Identification Number | 02293404 |
| Brand name | POSANOL |
| Common or Proper name | posaconazole Oral Suspension |
| Company Name | MERCK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | POSACONAZOLE |
| Strength(s) | 200MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 40MG/ML |
| ATC code | J02AC |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-01-20 |
| Actual start date | |
| Estimated end date | 2025-02-14 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2024-11-29 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-11-29 | French | Compare |
| v1 | 2024-11-29 | English | Compare |
Showing 1 to 2 of 2